2019

Oklahoma’s experimental Medicaid program is increasingly seen as a warning for the proponents of value-based pharmaceutical…

In mid-February 2019, at the American Medical Association’s National Advocacy Conference, Demetrios Kouzoukas, principal deputy…

Earlier this year, the Supreme Court of the United States declined to hear a case involving a Maryland law that attempted to…

On April 4, 2019, the Department of Justice announced settlements with three different pharmaceutical companies over allegations…

Late last month, it was announced that Duke University agreed to settle with the Department of Justice (DOJ) a case involving…

In a recent JAMA article, “Assessment of the FDA Risk Evaluation and Mitigation Strategy for Transmucosal Immediate-Release…

In February 2019, during a news conference at The Villages, Florida Governor Ron DeSantis proposed importing Canadian prescription…

Daniel Levinson, the inspector general of the United States Department of Health and Human Services (HHS) recently announced that…

As many of our readers may know, Congressional oversight and investigations do not have to conform to the same rules as law…

On March 26, 2019, in the midst of Affordable Care Act invalidation discussions, Speaker of the United States House of…